145 related articles for article (PubMed ID: 26715733)
21. NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression.
Palumbo P; Miconi G; Cinque B; Lombardi F; La Torre C; Dehcordi SR; Galzio R; Cimini A; Giordano A; Cifone MG
Oncotarget; 2017 Apr; 8(15):25582-25598. PubMed ID: 28424427
[TBL] [Abstract][Full Text] [Related]
22. MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2.
Yang C; Zhan H; Zhao Y; Wu Y; Li L; Wang H
Cell Death Dis; 2021 Jan; 12(1):14. PubMed ID: 33414423
[TBL] [Abstract][Full Text] [Related]
23. CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.
Chen Y; Ning J; Shu L; Wen L; Yan B; Wang Z; Hu J; Zhou X; Tao Y; Xia X; Huang J
J Neurooncol; 2024 Mar; 167(1):63-74. PubMed ID: 38427133
[TBL] [Abstract][Full Text] [Related]
24. NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR.
Alqudah MA; Agarwal S; Al-Keilani MS; Sibenaller ZA; Ryken TC; Assem M
PLoS One; 2013; 8(10):e77299. PubMed ID: 24143218
[TBL] [Abstract][Full Text] [Related]
25. RNA helicase DHX15 acts as a tumour suppressor in glioma.
Ito S; Koso H; Sakamoto K; Watanabe S
Br J Cancer; 2017 Oct; 117(9):1349-1359. PubMed ID: 28829764
[TBL] [Abstract][Full Text] [Related]
26. Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level.
Klank RL; Decker Grunke SA; Bangasser BL; Forster CL; Price MA; Odde TJ; SantaCruz KS; Rosenfeld SS; Canoll P; Turley EA; McCarthy JB; Ohlfest JR; Odde DJ
Cell Rep; 2017 Jan; 18(1):23-31. PubMed ID: 28052252
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of invasion and motility of high-grade gliomas in the brain.
Mair DB; Ames HM; Li R
Mol Biol Cell; 2018 Oct; 29(21):2509-2515. PubMed ID: 30325290
[TBL] [Abstract][Full Text] [Related]
28. TSPAN6 could serve as a prognostic biomarker for patients with glioma.
Zeng X; Xie Y; Xie Y; Zhang C
Asian J Surg; 2024 May; 47(5):2250-2252. PubMed ID: 38403542
[No Abstract] [Full Text] [Related]
29. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.
Valtorta S; Salvatore D; Rainone P; Belloli S; Bertoli G; Moresco RM
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781585
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-Let-7f reduces the vasculogenic mimicry of human glioma cells by regulating periostin-dependent migration.
Xue H; Gao X; Xu S; Zhang J; Guo X; Yan S; Li T; Guo X; Liu Q; Li G
Oncol Rep; 2016 Mar; 35(3):1771-7. PubMed ID: 26750768
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-584-3p reduces the vasculogenic mimicry of human glioma cells by regulating hypoxia-induced ROCK1 dependent stress fiber formation.
Xu S; Zhang J; Xue H; Guo X; Han X; Li T; Guo X; Gao X; Liu Q; Li G
Neoplasma; 2017; 64(1):13-21. PubMed ID: 27881000
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA TFAP2A-AS1 exerts promotive effects in non-small cell lung cancer progression via controlling the microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA.
Zhang Y; Ma L; Zhang T; Li P; Xu J; Wang Z
Oncol Res; 2021; 29(2):129-139. PubMed ID: 37305398
[TBL] [Abstract][Full Text] [Related]
33. Retracted Article: Overexpression of circ_0034642 contributes to hypoxia-induced glycolysis, cell proliferation, migration and invasion in gliomas by facilitating TAGLN2 expression
Kong B; Li M; Gao B; Han B; Zhao W; Wang F
RSC Adv; 2020 Jan; 10(2):897-908. PubMed ID: 35494452
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy.
Sohrabi B; Dayeri B; Zahedi E; Khoshbakht S; Nezamabadi Pour N; Ranjbar H; Davari Nejad A; Noureddini M; Alani B
Cancer Gene Ther; 2022 Aug; 29(8-9):1105-1116. PubMed ID: 35082400
[TBL] [Abstract][Full Text] [Related]
35. Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.
Dayakar A; Shanmukha KD; Kalangi SK
Mol Biol Rep; 2022 Jul; 49(7):6827-6846. PubMed ID: 35031927
[TBL] [Abstract][Full Text] [Related]
36. Differential and Common Signatures of miRNA Expression and Methylation in Childhood Central Nervous System Malignancies: An Experimental and Computational Approach.
Lambrou GI; Poulou M; Giannikou K; Themistocleous M; Zaravinos A; Braoudaki M
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771655
[TBL] [Abstract][Full Text] [Related]
37. Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma.
Richard SA
Dis Markers; 2020; 2020():8844313. PubMed ID: 33204365
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro.
Wang R; Liu L; Jiao J; Gao D
Cancer Manag Res; 2020; 12():8745-8756. PubMed ID: 33061572
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2.
Li L; Kong X; Zang M; Hu B; Fang X; Gui B; Hu Y
Cancer Manag Res; 2020; 12():2577-2587. PubMed ID: 32346311
[TBL] [Abstract][Full Text] [Related]
40. miR-584 inhibits cell proliferation, migration and invasion
Wang T; Feng J; Zhang A
Exp Ther Med; 2020 Mar; 19(3):2059-2066. PubMed ID: 32104266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
